Colon Cancer: It's CIN or CIMP
- 30 September 2008
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (19) , 5939-5940
- https://doi.org/10.1158/1078-0432.ccr-08-1596
Abstract
Combined genetic and epigenetic analysis of sporadic colon cancer suggest that it can no longer be viewed as a single disease. There are at least three different subsets with distinct clinico-pathologic features, with important implications for preventions, screening, and therapy.Keywords
All Related Versions
This publication has 10 references indexed in Scilit:
- CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal CancerClinical Cancer Research, 2008
- Targeted therapy of cancer: new roles for pathologists in colorectal cancerLaboratory Investigation, 2008
- Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerProceedings of the National Academy of Sciences, 2007
- The CpG Island Methylator Phenotype and Chromosomal Instability Are Inversely Correlated in Sporadic Colorectal CancerGastroenterology, 2007
- Differing DNA Methylation Patterns and Gene Mutation Frequencies in Colorectal Carcinomas from Middle Eastern CountriesClinical Cancer Research, 2005
- Epigenetic Changes in Solid and Hematopoietic TumorsSeminars in Oncology, 2005
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instabilityOncogene, 1999
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999
- Genetic instabilities in human cancersNature, 1998